Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support
Key facts
- Who runs it
- Yale University
- Where
- Chapel Hill, Minneapolis, New Haven, and The Bronx, United StatesSee the 4 sitesAlso in 1 other country, 1 site
- Trial code
- Status
- Completed
- People taking part
- 398 people enrolled
- Started
- 21 Apr 2021
- Ended
- 30 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transitions Clinic Network Primary Care
- Standard Primary Care
- Record updated
- 12 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- 18 years or older
- English and Spanish-speaking,
- Meeting current DSM-5 criteria for OUD
Who cannot take part
- women of child-bearing age will be excluded if they are pregnant
- acutely psychotic, suicidal or homicidal,
- require prescription opioids for acute pain, chronic pain or palliative care without OUD,
- have a planned relocation that makes it unlikely they would be able to complete the study and follow-up assessments,
- have a primary care provider that they already have established care with in the community,
Where in United States
Also in 1 other country, 1 site
- UNC- Chapel HillChapel Hill, United States
- Hennepin HealthcareMinneapolis, United States
- YaleNew Haven, United States
- Albert Einstein College of MedicineThe Bronx, United States
About the trial
What the trial wants to find out
TCN PATHS will recruit an anticipated 400 participants who are prescribed MOUD who are released from detention facilities. Each individual will be randomized to either 1) standard primary care (SPC) or 2) a Transitions Clinic Network (TCN) program primary care. Participants will be followed for a year and complete surveys at baseline and at month 1, 3, 6, 9, and 12. At each of these points research staff will confirm MOUD status. Urine drug screenings will be completed at baseline, month 1, 6, and 12 if the participant is not incarcerated. When possible, research staff will collect electronic health records.
The 2 groups in the trial
- Standard Primary CareExisting treatment, for comparison
Those randomized to the standard primary care arm will be referred to primary care and community Opioid Treatment Program (OTP). Participants may receive buprenorphine or Extended-release naltrexone (XR-NTX) through primary care or with a community addiction treatment provider.
- Transitions Clinic Network Primary CareTreatment being tested
Transitions Clinic Network (TCN)- participants in this arm will be referred to a TCN program for primary care and community Opioid Treatment Program (OTP). All TCN programs have the ability to prescribe buprenorphine and Extended-release naltrexone (XR-NTX) and assist with referrals to methadone. The primary features of the TCN include (1) primary care and onsite MOUD or referral to community treatment when indicated, (2) addressing social determinants of OUD and care coordination through a Community Health Worker (CHW), and (3) addressing the discrimination and stigma that exist based on incarceration.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 12 May 2026